Scotiabank raised the firm’s price target on Omega Healthcare (OHI) to $45 from $42 and keeps a Sector Perform rating on the shares. The firm is updating its price targets for U.S. Real Estate & REITs stocks under its coverage, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $50 from $45 at Citi
- Omega Healthcare Investors Reports Strong Q3 2025 Earnings
- Omega Healthcare Announces New $2 Billion Equity Offering
- Omega Healthcare: Strong Q3 Performance and Strategic Ventures Justify Buy Rating
- Omega Healthcare raises FY25 AFFO view to $3.08-$3.10 from $3.04-$3.07
